Subscribe

DCI Blog

All
All

Duke Cancer Institute (DCI) Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of DCI faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Karen E. Butler, Director of Communications, Duke Cancer Institute.

Heme Partners With OncLive For State Of The Science Summit

“Guess what!? We’re in Raleigh/Durham for the State of the Science Summit on Hematologic Malignancies with @DukeCancer — going to be a fantastic night ahead!” tweeted OncLive , the official website for the Oncology Specialty Group whose mission it is to provide resources and information oncology...

Duke Cancer Institute Authorized To Offer Commercial CAR T-Cell Therapy  

On Jan. 31, Duke Cancer Institute joined a select group of medical centers across the country (34 to date) certified and trained to administer Yescarta, the first Food and Drug Administration-approved CAR T-cell therapy for the treatment of adult patients with certain types of relapsed or...

December Newsmakers

Read here for a sample of some of the DCI physicians, physician-scientists and researchers whose work was featured in the media and academic journals this month. This list includes Henry Friedman, MD; Michael Morse, MD, David Rizzieri, MD; and many more.

March Newsmakers

Read here for a sample of some of the DCI physicians, physician-scientists and researchers whose work was featured in the media and academic journals this month. This list includes Michael Kastan, MD, PhD; Mark Dewhirst, DVM, PhD; Matthias Gromeier, MD; and many more.